Ji Yongling
Ji Yongling
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of Carbon-Ion Lattice Radiotherapy for Large Thoracic Tumors | Carbon Ion Radiotheray | Recruiting | Not applicable | 2026-08-04 | NCT07744074 | |
| Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC | Resectable Esophageal Cancer | Not yet recruiting | Phase 2 | 2026-02-04 | NCT07385664 | |
| Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2025-07-10 | NCT06379087 | |
| Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not stated | 2025-06-25 | NCT07035860 |